Skip to main content
John Krystal, MD, Psychiatry, West Haven, CT, Yale-New Haven Hospital

JohnHarrisonKrystalMD

Psychiatry West Haven, CT

Addiction

Robert L. McNeil, Jr. Professor of Psychiatry and Professor of Neuroscience; Chair, Department of Psychiatry; Chief of Psychiatry, Yale-New Haven Hospital; Director: NIAAA Center for the Translational Neuroscience of Alcoholism ; Director, Clinical Neuroscience Division, VA National Center for PTSD (VA Connecticut); Co-Director, Yale Center for Clinical Investigation, Yale University

Dr. Krystal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Krystal's full profile

Already have an account?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Psychiatry, 1985 - 1988
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterInternship, Transitional Year, 1984 - 1985
  • Yale School of Medicine
    Yale School of MedicineClass of 1984

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1986 - 2025
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2010

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Ketamine with Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia  
    Mohini Ranganathan, John H Krystal, JAMA Network Open
  • A Multicenter Study of Ketamine Effects on Functional Connectivity: Large Scale Network Relationships, Hubs and Symptom Mechanisms  
    Ragy R Girgis, Richard J Maddock, John D Ragland, Daniel C Javitt, Cameron S Carter, Joshua T Kantrowitz, Jeffrey Lieberman, John H Krystal, Lawrence S Kegeles, Willia..., ScienceDirect
  • Celebrating 50 Years of Biological Psychiatry: To the Future, and Beyond  
    John Krystal, MD, Biological Psychiatry
  • Join now to see all

Authored Content

  • Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.govMay 2020
  • Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.govMay 2020
  • Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.govMay 2020
  • Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.govMay 2020
  • Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.govMay 2020
  • F131. Genome-Wide Association Study Identifies Glutamate Ionotropic Receptor GRIA4 as a Risk Gene for Comorbid Nicotine Dependence and Major DepressionApril 2018
  • Join now to see all

Press Mentions

  • BioXcel Therapeutics Announces Promising Topline Results from Part 1 of Pivotal SERENITY III Trial of BXCL501 for at-Home Use in Acute Treatment of Agitation in Bipolar Disorders or Schizophrenia
    BioXcel Therapeutics Announces Promising Topline Results from Part 1 of Pivotal SERENITY III Trial of BXCL501 for at-Home Use in Acute Treatment of Agitation in Bipolar Disorders or SchizophreniaMay 25th, 2023
  • Flawed Protocol for Levodopa Clinical Trial Brings Retractions
    Flawed Protocol for Levodopa Clinical Trial Brings RetractionsMay 9th, 2023
  • Ketamine Has Become an at-Home Treatment for Depression, but Some Scientists Say That Set-up Is Too Risky
    Ketamine Has Become an at-Home Treatment for Depression, but Some Scientists Say That Set-up Is Too RiskyFebruary 23rd, 2023
  • Join now to see all

Grant Support

  • Pilot CoreNational Institute On Alcohol Abuse And Alcoholism2011
  • Administrative CoreNational Institute On Alcohol Abuse And Alcoholism2006–2011
  • Center For The Translational Neuroscience Of AlcoholismNational Institute On Alcohol Abuse And Alcoholism2001–2011
  • Cortical GABA Function In AlcoholismNational Institute On Alcohol Abuse And Alcoholism1999–2011
  • The Interactive Impact Of Cocaine And Schizophrenia On Prefrontal FunctionNational Institute On Drug Abuse2008–2010
  • A PET Study Of Ventral Striatum Dopamine Release DeficitsNational Institute On Alcohol Abuse And Alcoholism2007–2010
  • Ctr For Translational Neuroscience Of AlcoholNational Institute On Alcohol Abuse And Alcoholism2006–2010
  • Amino Acid Neurotransmitter Dysregulation In AlcoholismNational Institute On Alcohol Abuse And Alcoholism2004–2008
  • Symposium On Neuroimaging In AlcoholismNational Institute On Alcohol Abuse And Alcoholism2007
  • Moderate Human NMDA Receptor Function And Ethanol ResponseNational Institute On Alcohol Abuse And Alcoholism2007
  • Pilot Data Collection In Collaboration With The Ctna CoresNational Institute On Alcohol Abuse And Alcoholism2006–2007
  • Novel Glutamatergic Detoxification StrategiesNational Institute On Alcohol Abuse And Alcoholism2004–2006
  • Admistrative CoreNational Institute Of Mental Health2004
  • Symposium On Neuroimaging In AlcoholismNational Institute On Alcohol Abuse And Alcoholism2003
  • Amino Acid Neurotransmitter Dysregulation In AlcoholismNational Institute On Alcohol Abuse And Alcoholism1999–2003
  • Core--Statistics And Data ManagementNational Institute On Alcohol Abuse And Alcoholism2001–2002
  • Naltrexone Blockade Of NMDANational Institute On Alcohol Abuse And Alcoholism2000–2002
  • Core--Laboratory For Developmental NeurochemistryNational Institute Of Mental Health1998–2000
  • Core--Clinical Neuroscience And Experimental TherapeuticsNational Institute Of Mental Health1998–2000
  • Cortical GABA Levels In Schizophrenics/Detoxified Alcoholics/NormalsNational Center For Research Resources1996–1999
  • NMDA Dysregulation In AlcoholismNational Institute On Alcohol Abuse And Alcoholism1995–1997

Hospital Affiliations